High-tech Mobile Laboratory Brings Education and Training to Healthcare and Quality Assurance Professionals Across North America
Asia
Europe, Middle East, Africa
North America
bioMérieux Acquires From Anagnostec - Database and Expertise for Rapid Microbial Identification using Mass Spectrometry
12 April, 2010
bioMérieux announces today that it has agreed on the terms for the acquisition of certain assets from AnagnosTec, a company based in the greater Berlin area, specialized in microbial identification with MALDI-TOF* mass spectrometry technology.
bioMérieux's PREVI™ Isola Wins the 2010 - Medical Design Excellence Award
08 April, 2010
The award highlights the automated media streaker’s breakthrough technology.
bioMérieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Tool
11 March, 2010
Cost-effective chromogenic media ideal for VRE identification in hospitals and laboratories
bioMérieux Results 2009
08 March, 2010
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on Friday, March 5, 2010 to approve the consolidated financial statements for the year ended December 31, 2009. The meeting was chaired by Alain Mérieux and attended by the Statutory Auditors. The financial statements have been audited and the Statutory Auditors are in the process of issuing an unqualified opinion.
bioMérieux 2015
08 March, 2010
A powerful strategic vision for 2010-2015, driven by innovation and international development.
bioTheranostics Announces Commercial Availability of Expanded Tumor-Type Database for CancerTYPE ID® and the Launch of KRAS Testing
04 March, 2010
bioTheranostics, a bioMérieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing.
bioMérieux Launches the First Ready-to-Use Enrichment Culture Medium for the Simple Analysis of Campylobacter in Food Products
22 February, 2010
pr_22022010_small_thumb18.jpg bioMérieux, a world leader in the field of in vitro diagnostics, today announced the launch of its new, ready-to-use culture medium, CampyFood Broth (CFB) for the detection and enumeration of Campylobacter spp. This innovative broth will provide food processing companies with simple, complete and high quality solutions to help ensure the safety of their food products.
bioMérieux's VIDAS SLM, An Officially Recognized MethodSM for Testing Salmonella in Black Pepper
16 February, 2010
Solution Fully Validated and Recognized as an Official MethodSM
2009 Business Review
22 January, 2010
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for fourth-quarter and full-year 2009.